Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections

Journal of Clinical Epidemiology

Volumn 59, Issue 12, 2006, Pages 1266-1273

  McGregor, Jessina C ^a   Perencevich, Eli N ^a,b   Furuno, Jon P ^a   Langenberg, Patricia ^a   Flannery, Kathleen ^b   Zhu, Jingkun ^a   Fink, Jeffrey C ^a   Bradham, Douglas D ^a,b   Harris, Anthony D ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bacterial infections; Chronic disease; Comorbidity; Drug resistance, Bacterial; Risk adjustment

Indexed keywords

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CANCER; COMORBIDITY; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; KIDNEY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PEPTIC ULCER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; TRANSPLANTATION; VALIDATION PROCESS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

COMORBIDITY; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ADJUSTMENT; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 33750704638     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.01.016     Document Type: Article

References (45)

1. Kim T., Oh P.I., and Simor A.E. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 22 (2001) 99-104
2. Shaikh Z.H., Osting C.A., Hanna H.A., Arbuckle R.B., Tarr J.J., and Raad I.I. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect 51 (2002) 52-58
3. Tornieporth N.G., Roberts R.B., John J., Hafner A., and Riley L.W. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 23 4 (1996) 767-772
4. Memmel H., Kowal-Vern A., and Latenser B.A. Infections in diabetic burn patients. Diabetes Care 27 1 (2004) 229-233
5. Baillargeon J., Kelley M.F., Leach C.T., Baillargeon G., and Pollock B.H. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Clin Infect Dis 38 9 (2004) e92-e95
6. Naylor A.R., Hayes P.D., and Darke S. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg 21 4 (2001) 289-294
7. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 (2001) 178-182
8. Joels C.S., Matthews B.D., Sigmon L.B., Hasan R., Lohr C.E., Kercher K.W., et al. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections. Am Surg 69 6 (2003) 514-519
9. Peduzzi P., Concato J., Kemper E., Holford T.R., and Feinstein A.R. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49 (1996) 1373-1379
10. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
11. Harrell Jr. F.E., Lee K.L., Califf R.M., Pryor D.B., and Rosati R.A. Regression modelling strategies for improved prognostic prediction. Stat Med 3 (1984) 143-152
12. Moss M., Wellman D.A., and Cotsonis G.A. An appraisal of multivariable logistic models in the pulmonary and critical care literature. Chest 123 3 (2003) 923-928
13. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66 3 (2004) 411-421
14. Concato J., Feinstein A.R., and Holford T.R. The risk of determining risk with multivariable models. Ann Intern Med 118 3 (1993) 201-210
15. Charlson M., Ales K.L., Simon R., and MacKenzie C.R. Why predictive indexes perform less well in validation studies. Arch Intern Med 147 (1987) 2155-2161
16. Lesens O., Methlin C., Hansmann Y., Remy V., Martinot M., Bergin C., et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 24 12 (2003) 890-896
17. Cosgrove S.E., and Carmeli Y. Studies of bloodstream infection outcomes: reading between the lines. Infect Control Hosp Epidemiol 24 12 (2003) 884-886
18. Schneeweiss S., Seeger J.D., Maclure M., Wang P.S., Avorn J., and Glynn R.J. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154 9 (2001) 854-864
19. Iezzoni L.I. The risks of risk adjustment. JAMA 278 19 (1997) 1600-1607
20. Daley J., and Schwartz M. Developing risk-adjustment measures. In: Iezzoni L.I. (Ed). Risk Adjustment for Measuring Healthcare Outcomes (1997), Health Administration Press, Chicago, IL 279-329
21. de Groot V., Beckerman H., Lankhorst G.J., and Bouter L.M. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56 (2003) 221-229
22. McGregor J.C., Kim P.W., Perencevich E.N., Bradham D.D., Furuno J.P., Kaye K.S., et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 161 (2005) 483-493
23. Von Korff M., Wagner E.H., and Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 45 (1992) 197-203
24. Harris A.D., Smith D., Johnson J.A., Bradham D.D., and Roghmann M.C. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34 (2002) 340-345
25. Harris A.D., Perencevich E., Roghmann M.C., Morris G., Kaye K.S., and Johnson J.A. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46 3 (2002) 854-858
26. Kim P.W., Harris A.D., Roghmann M.C., Morris Jr. J.G., Strinivasan A., and Perencevich E.N. Epidemiological risk factors for isolation of ceftriaxone-resistant versus - susceptible citrobacter freundii in hospitalized patients. Antimicrob Agents Chemother 47 9 (2003) 2882-2887
27. Harris A.D., Nemoy L., Johnson J.A., Martin-Carnahan A., Smith D.L., Standiford H., et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 25 (2004) 105-108
28. Furuno J.P., Harris A.D., Wright M.O., McGregor J.C., Venezia R.A., Zhu J., et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 32 8 (2004) 436-440
29. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 3 (1988) 128-140
30. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. In: Olmstead R.N. (Ed). APIC Infection Control and Applied Epidemiology: Principles and Practice (1996), Mosby, St. Louis, MO A1-A20
31. Daley J. Validity of risk-adjustment methods. In: Iezzoni L.I. (Ed). Risk Adjustment for Measuring Healthcare Outcomes (1997), Health Administration Press, Chicago, IL 331-363
32. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
33. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 10 (1985) 818-829
34. Ash A., and Shwartz M. Evaluating the performance of risk-adjustment methods: dichotomous outcomes. In: Iezzoni L.I. (Ed). Risk Adjustment for Measuring Healthcare Outcomes (1997), Health Administration Press, Chicago, IL
35. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
36. Moons K.G., Harrell F.E., and Steyerberg E.W. Should scoring rules be based on odds ratios or regression coefficients?. J Clin Epidemiol 55 (2002) 1054-1055
37. Lemeshow S., and Hosmer Jr. D.W. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115 (1982) 92-106
38. Diamond G.A. What price perfection? Calibration and discrimination of clinical prediction models. J Clin Epidemiol 45 1 (1992) 85-89
39. Lemeshow S., and Le Gall J.R. Modeling the severity of illness of ICU patients. A systems update. JAMA 272 13 (1994) 1049-1055
40. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 3 (1988) 837-845
41. Dziekan G., Hahn A., Thune K., Schwarzer G., Schafer K., Daschner F.D., et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 46 4 (2000) 263-270
42. Graffunder E.M., and Venezia R.A. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49 6 (2002) 999-1005
43. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20 5 (1995) 1126-1133
44. Marshall C., Harrington G., Wolfe R., Fairley C.K., Wesselingh S., and Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 24 5 (2003) 322-326
45. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-85.